Oruka Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $22.2M | $7.4M |
| FY2017 | — | $10.3M | $8.7M |
| FY2018 | — | $6.0M | $6.6M |
| FY2019 | — | $7.6M | $8.4M |
| FY2020 | — | $46.5M | $49.1M |
| FY2021 | — | $51.0M | $53.4M |
| FY2022 | — | $41.7M | $42.4M |
| FY2023 | — | $37.0M | $37.4M |
| FY2024 | — | $1.0K | $61.6M |
| FY2025 | — | $471.9M | $46.9M |